MTOR and lung cancer: Taken together, these findings suggested that BDH1 might be a useful novel biomarker and therapeutic target for lung cancer metastases, and that PARP1‐mediated AMPK‐mTOR signalling pathway might play a critical role in BDH1‐induced autophagy, proliferation and metastases.